MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog

Journal of B.U.ON.

Volumn 19, Issue 1, 2014, Pages 228-236

  Li, Ling ^a   Zhou, Liya ^a   Li, Yuwen ^a   Lin, Sanren ^a   Tomuleasa, Ciprian ^b,c  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Ion Chiricuta Comprehensive Cancer Center   (Romania)

Author keywords

Gastric cancer; MiR 21; PDCD4; PTEN; Tumor suppressor genes

Indexed keywords

MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIGENETICS; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH CANCER; TUMOR INVASION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; RNA-BINDING PROTEINS; STOMACH NEOPLASMS;

EID: 84898912166     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29. (Pubitemid 29409471)
2. Yeoh KG. How do we improve outcomes for gastric cancer? J Gastroenterol Hepatol 2007;22:970-972.
3. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition, American Joint Committee on Cancer staging, proximal disease, and the 'different disease' hypothesis. Cancer 2000;88:921-932. (Pubitemid 30091113)
4. Correa P, Piazuelo MB, Camargo MG The future of gastrio cancer prevention. Gastric Cancer 2004;7:9-16.
5. Wang J, Wang Q, Liu H, Hu B, Zhou W, Cheng Y. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett 2010;297:137-143.
6. Li T, Lu YY, Zhao XD et al. MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene 2013 (in press).
7. Zhou C, Li X, Zhang X et al. microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFKB signaling in human gastric carcinoma cells. Int J Oncol 2013;42:635-642.
8. Yamanaka S, Olaru AV, An F et al. MicroRNA-21 inhibits Serpinil, a gene with novel tumour suppressive effects in gastric cancer. Dig Liver Dis 2012;44:589-596.
9. Van Cutsem E, Dicato M, Geva R et al. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol 2011;22 (Suppl 5):vl-9.
10. Li H, Lu P, Lu Y et al. Predictive factors of lymph node metastasis in undifferentiated early gastric cancers and application of endoscopic mucosal resection. Surg Oncol 2010; 19:221-226.
11. Tahara T, Shibata T, Yamashita H, Yoshioka D, Hirata I, Arisawa T. Promoter methylation status of multidrug resistance 1 (MDR1) gene in noncancerous gastric mucosa correlates with Helicobacter Pylori infection and gastric cancer occurrence. Cancer Invest 2010;28:711-716.
12. Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005;4:1179-1184. (Pubitemid 41365387)
13. Calin GA, Sevignani C, Dumitru CD et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004. (Pubitemid 38327724)
14. Calin GA, Croce CM. MicroRNA signatures in human cancers.Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
15. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006;25:6188-6196. (Pubitemid 44527849)
16. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-269.
17. Emmrich S, Pützer BM. Checks and balances: E2F-mi- croRNA crosstalk in cancer control. Cell Cycle 2010;9:2555-2567.
18. Nan Y, Han L, Zhang A et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 2010;1359:14-21.
19. Dykxhoorn DM. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 2010;70:6401-6406.
20. Kota J, Chivukula RR, O'Donnell KA et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-1017.
21. Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010;10:297-308.
22. Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. Gut 2009;58:1546-1554.
23. Rosenfeld N, Aharonov R, Meiri E et al. MicroRNAs ac- curately identify cancer tissue origin. Nat Biotechnol 2008;26:462-469. (Pubitemid 351501813)
24. Wijnhoven BP, Michael MZ, Watson DI. MicroRNAs and cancer. Br J Surg 2007;94:23-30. (Pubitemid 46142727)
25. Wei N, Liu SS, Chan KK, Ngan HY.Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer. PLoS One 2012;7(1):e30311.
26. Ferris WF, Marriott CE, Ali T, Landy C, Campbell SC, Macfarlane WM. Tumor suppressor Pdcd4 is a major transcript that is upregulated during in vivo pancreatic islet neogenesis and is expressed in both beta-cell and ductal cell lines. Pancreas 2011;40:61-66.
27. Wang WQ, Zhang H, Wang HB et al. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway. Mol Diagn Ther 2010;14:155-161.
28. Haider KH, Idris NM, Kim HW, Ahmed RP, Shujia J, Ashraf M. MicroRNA-21 is a key determinant in IL11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res 2010;88:168-178.
29. Shen XH, Han YJ, Zhang DX, Cui XS, Kim NH. A link between the interleukin-6/Stat3 anti-apoptotic pathway and microRNA-21 in preimplantation mouse embryos. Mol Reprod Dev 2009;76:854-562.
30. Meng F, Henson R, Lang M et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006;130:2113-2129. (Pubitemid 43816961)
31. Qin X, Yan L, Zhao X, Li C, Fu Y. microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett 2012;4:1290-1296.
32. Xiong B, Cheng Y, Ma L, Zhang C. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol 2013;42:219-228.
33. Gwak HS, Kim TH, Jo GH et al. Silencing of microR-NA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One 2012;7(10):e47449.
34. Wang B, Zhang Q. The expression and clinical significanoe of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 2012;138:1659-1666.